RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site such as personalized content. Please see our Privacy Policy for more information.

RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
18 September 2020
This update includes   a new entries for PF-00835321 and updated information on COVI-GUARD, Veklury, Bucillamine, LY-CoV555 and REGN-COV2.

Latest News

ALL
17 September 2020
Medical device registries can provide rich fields for data mining when real-world evidence is sought. But most medical devices will never land on a registry. Does this mean that these manufacturers will not be able to find a source of real-world d...
17 September 2020
This update includes new information on vaccine candidates from Oxford University/AstraZeneca, Pfizer/BioNTech, Voltron Therapeutics/Hoth Therapeutics, and Bharat Biotech.
17 September 2020
The European Medicines Agency is on the verge of releasing revised guidance for advanced therapy medicinal products containing genetically modified cells, which includes chimeric antigen receptor (CAR)-T cell therapies.
16 September 2020
As the coronavirus pandemic swept through major US cities in the spring of 2020, the US Food and Drug Administration took unprecedented steps to address shortages and bring tests and potential therapies online with alacrity.  
16 September 2020
As the coronavirus pandemic swept through major US cities in the spring of 2020, the US Food and Drug Administration took unprecedented steps to address shortages and bring tests and potential therapies online with alacrity.  
16 September 2020
Investigators should use a patient-reported outcomes approach, with an emphasis on electronic data collection, in their research on therapies to treat or prevent COVID-19, according to a new guidance from the US Food and Drug Administration.